ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
-10.88%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$46.7M
AUM Growth
+$46.7M
(-75%)
Cap. Flow
-$123M
Cap. Flow
% of AUM
-264.66%
Top 10 Holdings %
Top 10 Hldgs %
69.4%
Holding
38
New
8
Increased
2
Reduced
12
Closed
16
Top Buys
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$2.73M |
| 2 |
DexCom
DXCM
|
$2.2M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
$1.88M |
| 4 |
AMRN
Amarin Corp
AMRN
|
$1.58M |
| 5 |
Tandem Diabetes Care
TNDM
|
$1.12M |
Top Sells
| 1 |
Inogen
INGN
|
$12.8M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$11.6M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$10.1M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$9.12M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$8.56M |
Sector Composition
| 1 | Healthcare | 91.36% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Avantor
AVTR
$8.74B
| – | – |
-122,962
| Closed | -$2.35M |
|
27
Centene
CNC
$14.8B
| – | – |
-147,638
| Closed | -$7.74M |
|
28
Elevance Health
ELV
$72.4B
| – | – |
-16,581
| Closed | -$4.68M |
|
|
CBIO
29
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| – | – |
-4,980
| Closed | -$5.94M |
|
|
30
Inogen
INGN
$213M
| – | – |
-191,970
| Closed | -$12.8M |
|
31
iRhythm Technologies
IRTC
$5.67B
| – | – |
-14,854
| Closed | -$1.18M |
|
|
32
Jazz Pharmaceuticals
JAZZ
$7.99B
| – | – |
-63,940
| Closed | -$9.12M |
|
33
Opko Health
OPK
$1.1B
| – | – |
-1,628,666
| Closed | -$3.97M |
|
34
Pacira BioSciences
PCRX
$1.22B
| – | – |
-84,735
| Closed | -$3.69M |
|
35
Sarepta Therapeutics
SRPT
$1.98B
| – | – |
-11,050
| Closed | -$1.68M |
|
36
UnitedHealth
UNH
$279B
| – | – |
-30,767
| Closed | -$7.51M |
|
|
VRAY
37
DELISTED
ViewRay, Inc.
VRAY
| – | – |
-443,973
| Closed | -$3.91M |
|
|
HMSY
38
DELISTED
HMS Holdings Corp.
HMSY
| – | – |
-25,598
| Closed | -$829K |
|